What are the orders for acute seizure management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acute Seizure Management Orders

For any actively seizing patient, immediately administer IV lorazepam 4 mg at 2 mg/min (or 0.1 mg/kg in pediatrics, max 2 mg) as first-line treatment, with airway equipment at bedside and continuous vital sign monitoring. 1, 2, 3

Immediate Actions (First 0-5 Minutes)

Initial Assessment & Stabilization:

  • Assess circulation, airway, breathing (CAB) and position patient on side in recovery position 1
  • Establish IV access immediately 2, 3
  • Check fingerstick glucose and correct if <60 mg/dL 1, 2
  • Apply continuous cardiac monitoring, pulse oximetry, and blood pressure monitoring 1, 4
  • Have airway equipment and bag-valve-mask immediately available at bedside 5
  • Administer high-flow oxygen 1

First-Line Anticonvulsant (Benzodiazepines):

  • IV lorazepam 4 mg at 2 mg/min (adults) or 0.1 mg/kg (max 2 mg) in pediatrics 1, 2, 3
  • May repeat once after 5-10 minutes if seizure continues 2, 3
  • Alternative if no IV access: Intramuscular midazolam 10 mg (adults) or 0.2 mg/kg (pediatrics) 1
  • Alternative: Intranasal midazolam or buccal midazolam (0.2-0.5 mg/kg) 1, 6

Second-Line Treatment (If Seizures Continue After 10-15 Minutes)

Status epilepticus is defined as seizures lasting >5 minutes and requires immediate escalation to second-line agents. 1, 2

Choose ONE of the following second-line agents (all have similar efficacy 68-88%): 1, 2, 3

Option 1: Fosphenytoin (Traditional Choice)

  • Dose: 20 mg PE/kg IV at maximum rate of 50 mg/min (adults) or 1-3 mg/kg/min (pediatrics) 1, 2, 4
  • Efficacy: 84% seizure control 2
  • Monitoring: Requires continuous ECG and blood pressure monitoring due to 12% hypotension risk and cardiac arrhythmia risk 1, 2, 4
  • Infusion requirements: Use 0.22-0.55 micron in-line filter, dilute in normal saline to ≥5 mg/mL concentration 4

Option 2: Valproate (Preferred for Cardiovascular Safety)

  • Dose: 20-30 mg/kg IV over 5-20 minutes 1, 2, 3
  • Efficacy: 88% seizure control with 0% hypotension risk 2, 3
  • Advantage: Less hypotension than fosphenytoin while maintaining similar efficacy 2

Option 3: Levetiracetam (Preferred for Elderly/Cardiac Patients)

  • Dose: 30 mg/kg IV (max 2500-3000 mg) over 5-10 minutes 1, 2, 3
  • Efficacy: 68-73% seizure control 2, 3
  • Advantage: Minimal cardiovascular effects, no cardiac monitoring required 2, 3

Option 4: Phenobarbital

  • Dose: 20 mg/kg IV over 10 minutes 1, 2
  • Efficacy: 58.2% seizure control 2
  • Caution: Higher risk of respiratory depression 2

Third-Line Treatment: Refractory Status Epilepticus (If Seizures Continue After 30-40 Minutes)

Refractory status epilepticus is defined as seizures continuing despite benzodiazepines and one second-line agent. 2, 3

Immediate Actions:

  • Transfer to ICU 1, 3
  • Initiate continuous EEG monitoring 1, 2, 3
  • Prepare for intubation and mechanical ventilation 2, 3

Choose ONE anesthetic agent:

Option 1: Midazolam Infusion (First Choice)

  • Loading dose: 0.15-0.20 mg/kg IV 1, 2, 3
  • Continuous infusion: Start at 1 mg/kg/min, titrate up by 1 mg/kg/min every 15 minutes to max 5 mg/kg/min 2, 3
  • Efficacy: 80% seizure control 2, 3
  • Hypotension risk: 30% 2, 3

Option 2: Propofol (For Intubated Patients)

  • Loading dose: 2 mg/kg bolus 1, 2, 3
  • Continuous infusion: 3-7 mg/kg/hour, titrate to EEG burst suppression 2, 3
  • Efficacy: 73% seizure control 2, 3
  • Hypotension risk: 42% 2
  • Advantage: Shorter ventilation time (4 days vs 14 days with pentobarbital) 2

Option 3: Pentobarbital (Most Effective but Highest Risk)

  • Loading dose: 13 mg/kg 2, 3
  • Continuous infusion: 2-3 mg/kg/hour 2, 3
  • Efficacy: 92% seizure control (highest) 2, 3
  • Hypotension risk: 77% (highest) 2

Concurrent Diagnostic Workup

Search for and treat reversible causes simultaneously: 2, 3

  • Hypoglycemia (check fingerstick glucose immediately) 1, 2
  • Hyponatremia (send basic metabolic panel) 2, 3
  • Hypoxia (pulse oximetry, arterial blood gas) 2
  • Drug toxicity or withdrawal syndromes (urine drug screen, alcohol level, medication history) 2, 3
  • CNS infection (consider lumbar puncture after stabilization) 2, 3
  • Ischemic stroke or intracerebral hemorrhage (CT head non-contrast) 2, 3

EMS Activation Criteria

Activate emergency response system for: 1

  • First-time seizure 1
  • Seizure lasting >5 minutes 1
  • Multiple seizures without return to baseline between episodes 1
  • Seizure in infant <6 months of age 1
  • Seizure in pregnant patient 1
  • Seizure with traumatic injury, difficulty breathing, or choking 1
  • Seizure occurring in water 1
  • Patient does not return to baseline within 5-10 minutes after seizure stops 1

Critical Safety Measures

DO NOT: 1

  • Restrain the seizing patient 1
  • Place anything in the patient's mouth 1, 5
  • Give oral medications, food, or liquids during or immediately after seizure 1, 5
  • Use neuromuscular blockers alone (they only mask motor manifestations while allowing continued electrical seizure activity and brain injury) 2
  • Skip directly to third-line agents without trying benzodiazepines and a second-line agent first 2

DO: 1

  • Stay with the patient continuously 1
  • Clear area around patient to prevent injury 1
  • Position patient on side in recovery position 1
  • Monitor respiratory status continuously and be prepared to provide ventilatory support 1, 2, 3

Maintenance Therapy After Seizure Control

After resolution of status epilepticus, administer maintenance doses: 1

  • Lorazepam 0.05 mg/kg (max 1 mg) IV every 8 hours for 3 doses 1
  • Levetiracetam 15-30 mg/kg IV every 12 hours 1
  • Phenobarbital 1-3 mg/kg IV every 12 hours (if used) 1
  • Continue the second-line agent that was effective at appropriate maintenance dosing 3

Special Considerations

Pediatric Dosing Adjustments:

  • Lorazepam: 0.05-0.1 mg/kg IV (max 2 mg per dose) 1
  • Fosphenytoin: 1-3 mg/kg/min or 50 mg/min, whichever is slower 4
  • All second-line agents: Use weight-based dosing as specified above 1

Post-Ictal Period:

  • Expect confusion and sedation for several minutes to hours after seizure cessation 1
  • Continue monitoring until patient returns to baseline mental status 1, 7
  • Distinguish between post-ictal sedation and continued non-convulsive status epilepticus if consciousness does not improve 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Status Epilepticus Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Status Epilepticus Management and Chronic Seizure Control

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Seizure Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.